Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- FDA will favor rivaroxaban for ACS indications at May 23 panel - TheHeart.Org
- FDA will favor rivaroxaban for ACS indications at May 23 panelTheHeart
- DC Week: Feds Unveil New Alzheimer's Plan - MedPage Today
- MedPage TodayDC Week: Feds Unveil New Alzheimer's PlanMedPage Today
- Approval of Generic Clopidogrel a Boon for Patients or Payors? - Family Practice News Digital Network
- Approval of Generic Clopidogrel a Boon for Patients or Payors?Family Practice News Digital NetworkAnd second, “the availability of cheaper clopidogrel will discourage doctors from using prasugrel or ticlopidine, even though we know that those drugs are superior for the indication and may have real advantages for some of our patients
- Résultats à 10 ans du premier stent biodégradable identiques à ceux d'un stent nu - TheHeart.org
- Résultats à 10 ans du premier stent biodégradable identiques à ceux d'un stent nuTheHeart
